Classes
DEA Class; Rx
Common Brand Names; Novahistine DH
- Antitussives, Narcotic Combos
Description
Dihydrocodeine: Narcotic agonist analgesic with antitussive activity, mu receptor agonist
Chlorpheniramine: Histamine H1-receptor antagonist
Phenylephrine: Alpha-adrenergic stimulator with weak beta-adrenergic activity; produces systemic vasoconstriction of arteries and arterioles.
Indications
Contraindications
Codeine
Hypersensitivity
Acute abdominal condition, diarrhea associated w/ toxins, pseudomembranous colitis, respiratory depression
Asthma (acute), inflammatory bowel disease, respiratory impairment
Chlorpheniramine
Acute asthma, sleep apnea
Phenylephrine
Hypsesensitivity
Severe HTN, severe CAD
Within 14 days of nonselective MAO inhibitor therapy (risk of hypertensive reaction)
Newborn, preemies
Adverse Effects
Codeine
Bradycardia, hypotension, tachycardia
Confusion, dizziness, false feeling of well being, headache, lightheadedness, malaise, paradoxical CNS stimulation, restlessness, weakness
Rash, urticaria
Anorexia, nausea, vomiting, xerostomia
LFT’s increased
Ureteral spasm, urination decreased
Dyspnea
Burning at injection site, blurred vision, histamine release
Chlorpheniramine
Anticholinergic
Somnolence
Constipation
Diarrhea
Nausea
Vomiting
Blurred vision
Codeine
Hypotension, with IV use
Seizure, with excessive doses
Anaphylactoid reaction (rare)
Respiratory depression
Phenylephrine
Hypertension
Severe peripheral and visceral vasoconstriction
Pallor
Reflex tachycardia
Anxiety
Dizziness
Headache
Insomnia,Nervousness
Restlessness
Metabolic acidosis
Gastric irritation
Nausea
Decreased renal perfusion
Extravasation of IV administration may lead to necrosis and sloughing of surrounding tissue
Excitability
Warnings
Codeine
Cardiac arrhythmias, drug abuse/dependence, emotional lability, gallbladder disease, head injury, hepatic impairment, hypothyroidism, increased ICP, prostatic hypertrophy, renal impairment, seizures with epilepsy, urethral stricture, urinary tract surgery
Risk of life threatening side effects in nursing babies, especially if mother is an ultra rapid metabolizer of codeine
Ibuprofen is more effective than codeine for pain from musculoskeletal injuries in children
Chlorpheniramine
May cause CNS depression (patient should not operate heavy machinery
Caution in patients with asthma, thyroid dysfunction, hypertension, ischemic heart disease, increased intraocular pressure, or prostatic hyperplasia/urinary obstruction
Phenylephrine
Caution in diabetes mellitus, cardiovascular disease, prostatic hyperplasia, hyperthyroidism, and increased intraocular pressure
Pregnancy and Lactation
Pregnancy category: C
Not known whether distributed in breast milk, use caution
Maximum Dosage
5-10 mL PO q4-6hr, up to 40 mL/24 hr
Pediatric
< 2 years: Not recommended
2-6 years: 1.25-2.5 mL PO q4-6hr PRN, up to 10 mL/24 hr
6-12 years: 2.5-5 mL PO q4-6hr, up to 20 mL/24 hr
>12 years: 5-10 mL PO q4-6hr, up to 40 mL/24 hr
How supplied
Dihydrocodeine/chlorpheniramine/phenylephrine
oral liquid: Schedule III
- (7.5mg/2mg/5mg)/5mL
oral syrup: Schedule V
- (3mg/2mg/7.5mg)/5mL
- (3mg/5mg/20mg)/5mL